Curebase Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 39

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $40M

  • Investors
  • 18

Curebase General Information

Description

Developer of a patient enrollment and engagement platform designed to offer virtual studies for end-to-end clinical trial execution. The company's platform streamlines participant eligibility, enrollment, education, and consent while offering in-application protocol guidance and simple document scanning, enabling medical providers to train and educate in-house medical teams with improved speed and reduce cost.

Contact Information

Website
www.curebase.ai
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 548 Market Street
  • PMB 86319
  • San Francisco, CA 94104-5401
  • United States
+1 (628)
Primary Industry
Business/Productivity Software
Other Industries
Education and Training Services (B2B)
Other Healthcare Technology Systems
Vertical(s)
Digital Health, SaaS, Artificial Intelligence & Machine Learning, HealthTech
Corporate Office
  • 548 Market Street
  • PMB 86319
  • San Francisco, CA 94104-5401
  • United States
+1 (628)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Curebase Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series B) 05-May-2022 $40M Completed Generating Revenue
5. Early Stage VC (Series A) 22-Apr-2021 Completed Generating Revenue
4. Early Stage VC Completed Generating Revenue
3. Debt - PPP 30-Jun-2020 Completed Generating Revenue
2. Seed Round 31-Oct-2018 $2.51M $2.63M Completed Generating Revenue
1. Accelerator/Incubator 22-Aug-2018 $120K $120K Completed Generating Revenue
To view Curebase’s complete valuation and funding history, request access »

Curebase Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series B
Series A-1
Series A 3,861,887 $0.000010 6% $3.88 $3.88 1x $3.88 16.94%
Seed 2,908,261 $0.000010 6% $0.86 $0.86 1x $0.86 12.75%
To view Curebase’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Curebase Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a patient enrollment and engagement platform designed to offer virtual studies for end-to-end clinical tria
Business/Productivity Software
San Francisco, CA
39 As of 2025

Atlanta, GA
 

Eagan, MN
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Curebase Competitors (14)

One of Curebase’s 14 competitors is Florence (Business/Productivity Software), a Venture Capital-Backed company based in Atlanta, GA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Florence (Business/Productivity Software) Venture Capital-Backed Atlanta, GA
ImageTrend Private Equity-Backed Eagan, MN
TrialX Corporation New York, NY
Welligent Private Equity-Backed Norfolk, VA
Medrio Venture Capital-Backed San Francisco, CA
You’re viewing 5 of 14 competitors. Get the full list »

Curebase Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Curebase Investors (18)

Investor Name Investor Type Holding Investor Since Participating Rounds
10X Capital Venture Capital Minority
Acrew Capital Venture Capital Minority
Breyer Capital Venture Capital Minority
Calm Ventures Venture Capital Minority
Future Planet Capital Venture Capital Minority
You’re viewing 5 of 18 investors. Get the full list »

Ready to get started?

Request a free trial

Curebase FAQs

  • When was Curebase founded?

    Curebase was founded in 2017.

  • Where is Curebase headquartered?

    Curebase is headquartered in San Francisco, CA.

  • What is the size of Curebase?

    Curebase has 39 total employees.

  • What industry is Curebase in?

    Curebase’s primary industry is Business/Productivity Software.

  • Is Curebase a private or public company?

    Curebase is a Private company.

  • What is the current valuation of Curebase?

    The current valuation of Curebase is .

  • What is Curebase’s current revenue?

    The current revenue for Curebase is .

  • How much funding has Curebase raised over time?

    Curebase has raised $59M.

  • Who are Curebase’s investors?

    10X Capital, Acrew Capital, Breyer Capital, Calm Ventures, and Future Planet Capital are 5 of 18 investors who have invested in Curebase.

  • Who are Curebase’s competitors?

    Florence (Business/Productivity Software), ImageTrend, TrialX, Welligent, and Medrio are some of the 14 competitors of Curebase.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process